Clinical Trial Update: A Study to Evaluate Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Children (MK-0869-219) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating aprepitant for prevention of postoperative nausea and vomiting in children has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting in Children

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Post-operative Nausea, Post-operative Vomiting | Phase 2 | Status: COMPLETED | Results posted: 2017-09-06